Hye-Jin Kim

Hye-Jin Kim

Auto-generated profile, based on publicly available information

Hye-Jin Kim

Center for Vaccine Research, National Institute of Infectious Diseases, Korea National Institute of Health , Cheongju, Republic of Korea

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2023 in Journal of Medical Virology
Verified
Journal Article
Closed access
JYJinyoung Yang
Jinyoung Yang
HKHye‐Jin Kim
Hye‐Jin Kim
JKJun‐Won Kim
Jun‐Won Kim
JBJinYang Baek
JinYang Baek
YLYoung Jae Lee
Young Jae Lee
JKJae‐Hoon Ko
Jae‐Hoon Ko

29 November 2024 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
HKHyun Myung Kang
Hyun Myung Kang
HKHye-Jin Kim
Hye-Jin Kim
JJJiwon Jung
Jiwon Jung
JAJin Young Ahn
Jin Young Ahn
KSKyoung-Ho Song
Kyoung-Ho Song
JKJae-Hoon Ko
Jae-Hoon Ko
With the transition from the coronavirus disease 2019 (COVID-19) pandemic into endemicity, changes in group immunity and the effect of updated XBB.1.5 monovalent vaccine (MonoV) need to be investigated. A multicenter vaccine cohort was followed for 3 years, and the investigation period was classified into the pre-Omicron, Omicron, and endemic eras. Thirteen sampling points were assessed, including pre- and post-MonoV administration. Specimens were classified as vaccinated, molecularly or serologically diagnosed breakthrough infection (BI), natural boosting (NB), or waned. A total of 327 healthcare workers contributed 2645 blood samples from March 2021 to December 2023. The log10 anti-spike protein antibody (SAb) levels, elevated by vaccination, declined linearly in the pre-Omicron era, were maintained during the Omicron era due to BIs, and increased in the endemic era (slope = 0.02, P = .02) without additional vaccination. NB cases increased significantly across the epidemiologic eras. The incidence rate ratios were 2.72 (P < .001) for Omicron/pre-Omicron and 3.39 (P < .001) for endemic/Omicron. Plaque reduction neutralization test (PRNT) titers against circulating strains (XBB.1.5 and XBB.1.9.1) in the NB group maintained previous levels, but ratios to wild-type PRNT and fold changes exhibited significantly enhanced activity. The XBB.1.5 MonoV increased PRNT by 5.8-fold against XBB.1.5 and 6.6-fold against JN.1, showing stronger enhancement against subsequent epidemic strains than the bivalent vaccine. Group immunity in the COVID-19 endemic era exhibited maintained SAb levels and adjusted neutralizing activities through BI and NB. The XBB.1.5 MonoV significantly enhanced neutralizing activity against the vaccine strain and robust immunity against the subsequent epidemic JN.1 strain.

28 February 2023 in Osong Public Health and Research Perspectives
Verified
Journal Article
Open access
HKHye-Jin Kim
Hye-Jin Kim
JKJieun Kim
Jieun Kim
YJYoon Suk Jang
Yoon Suk Jang
HPHanul Park
Hanul Park
JKJong Mu Kim
Jong Mu Kim
SLSang Eun Lee
Sang Eun Lee
Objectives: The coronavirus disease 2019 (COVID-19) pandemic has continued since its first detection in the Republic of Korea on January 20, 2020. This study describes the early countermeasures used to minimize the risk of COVID-19 outbreaks during cohort quarantine and compares the epidemiological characteristics of 2 outbreaks in long-term care facilities (LTCFs) in Gwangju Metropolitan City in summer 2020.Methods: An epidemiological investigation was conducted via direct visits. We investigated epidemiological characteristics, including incidence, morbidity, and mortality rates, for all residents and staff members. Demographic characteristics were analyzed using a statistical program. Additionally, the method of managing infection in LTCFs is described.Results: Residents and caregivers had high incidence rates in LTCF-A and LTCF-B, respectively. LTCF-B had a longer quarantine period than LTCF-A. The attack rate was 20.02% in LTCF-A and 27.9% in LTCF- B. The mortality rate was 2.3% (1/43) in LTCF-B, the only facility in which a COVID-19 death occurred.Conclusion: Extensive management requires contact minimization, which involves testing all contacts to mitigate further transmission in the early stages of LTCF outbreaks. The findings of this study can help inform and prepare public health authorities for COVID-19 outbreaks, particularly for early control in vulnerable facilities.